Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors

BACKGROUND: We performed meta-analysis to gather more evidence regarding clinical-molecular subgroups associated with better overall survival (OS) in advanced melanoma treated with checkpoint inhibitors. MATERIALS AND METHODS: We performed a systematic search of PubMed, Scopus, Cochrane Library, and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Oncol
Päätekijät: Badami, Sunil, Upadhaya, Sunil, Velagapudi, Ravi Kanth, Mikkilineni, Pushyami, Kunwor, Ranju, Al Hadidi, Samer, Bachuwa, Ghassan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2018
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6077519/
https://ncbi.nlm.nih.gov/pubmed/30112001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6279871
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia